|
Diabetes, Vol 44, Issue 4 431-436, Copyright © 1995 by American Diabetes Association
Plasma endothelin-1 levels in obese hypertensive and normotensive men
C Ferri, C Bellini, G Desideri, L Di Francesco, R Baldoncini, A Santucci and G De Mattia
University La Sapienza, Institute of I Clinica Medica, Rome, Italy.
Plasma endothelin-1 (ET-1) levels were studied in 15 obese hypertensive
(mean age 48.5 +/- 3.9 years) and 15 obese normotensive men (mean age 49.5
+/- 3.6 years) before and after weight loss due to an 800 kcal/day diet
lasting 12 weeks. Circulating peptide concentrations were also assessed in
nonobese hypertensive (n = 11) and normotensive men (n = 12). Baseline
plasma ET-1 levels were similar in obese hypertensive (0.87 +/- 0.22 pg/ml)
and obese normotensive men (0.91 +/- 0.30 pg/ml). In seven obese
hypertensive men, caloric restriction normalized blood pressure levels
(systolic: from 166.6 +/- 8.1 to 145.0 +/- 6.3 mmHg, P < 0.0001;
diastolic: from 106.6 +/- 5.1 to 89.1 +/- 2.0 mmHg, P < 0.0001) and
decreased body mass index (BMI) (from 33.4 +/- 1.6 to 29.6 +/- 2.1 kg/m2, P
< 0.002) and plasma ET-1 levels (from 0.93 +/- 0.21 to 0.64 +/- 0.26
pg/ml, P < 0.05). In the remaining obese hypertensive men (n = 8), blood
pressure levels were not normalized by caloric restriction despite a
significant decrease of BMI and plasma ET-1 levels (from 0.83 +/- 0.23 to
0.60 +/- 0.16 pg/ml, P < 0.04). Weight loss also significantly decreased
BMI and ET-1 (from 0.91 +/- 0.30 to 0.65 +/- 0.19 pg/ml, P < 0.01) in
obese normotensive men. Baseline ET-1 and fasting insulin levels were
significantly correlated in obese hypertensive (r = 0.518, P < 0.05) and
obese normotensive men (r = 0.535, P < 0.04).(ABSTRACT TRUNCATED AT 250
WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C.-C. Juan, T.-Y. Chuang, C.-L. Chang, S.-W. Huang, and L.-T. Ho
Endothelin-1 Regulates Adiponectin Gene Expression and Secretion in 3T3-L1 Adipocytes via Distinct Signaling Pathways
Endocrinology,
April 1, 2007;
148(4):
1835 - 1842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ahlborg, A. Shemyakin, F. Bohm, A. Gonon, and J. Pernow
Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients With Insulin Resistance and Coronary Artery Disease
Diabetes Care,
March 1, 2007;
30(3):
591 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Silver, S. D. Beske, D. D. Christou, A. J. Donato, K. L. Moreau, I. Eskurza, P. E. Gates, and D. R. Seals
Overweight and Obese Humans Demonstrate Increased Vascular Endothelial NAD(P)H Oxidase-p47phox Expression and Evidence of Endothelial Oxidative Stress
Circulation,
February 6, 2007;
115(5):
627 - 637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-L. Tharaux, I. Hagege, S. Placier, M. Vayssairat, A. Kanfer, R. Girot, and J.-C. Dussaule
Urinary endothelin-1 as a marker of renal damage in sickle cell disease
Nephrol. Dial. Transplant.,
November 1, 2005;
20(11):
2408 - 2413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Usui, T. Imamura, J. L. Babendure, H. Satoh, J.-C. Lu, C. J. Hupfeld, and J. M. Olefsky
G Protein-Coupled Receptor Kinase 2 Mediates Endothelin-1-Induced Insulin Resistance via the Inhibition of Both G{alpha}q/11 and Insulin Receptor Substrate-1 Pathways in 3T3-L1 Adipocytes
Mol. Endocrinol.,
November 1, 2005;
19(11):
2760 - 2768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Strawbridge and J. S. Elmendorf
Phosphatidylinositol 4,5-Bisphosphate Reverses Endothelin-1-Induced Insulin Resistance via an Actin-Dependent Mechanism
Diabetes,
June 1, 2005;
54(6):
1698 - 1705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Juan, C.-L. Chang, Y.-H. Lai, and L.-T. Ho
Endothelin-1 induces lipolysis in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab,
June 1, 2005;
288(6):
E1146 - E1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Diamanti-Kandarakis, K Alexandraki, A Protogerou, C Piperi, C Papamichael, A Aessopos, J Lekakis, and M Mavrikakis
Metformin administration improves endothelial function in women with polycystic ovary syndrome
Eur. J. Endocrinol.,
May 1, 2005;
152(5):
749 - 756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-P. Xu, M.-S. Chen, Y.-Z. Wang, Q. Yi, S.-B. Lin, A. F. Chen, and J.-D. Luo
Leptin Induces Hypertrophy via Endothelin-1-Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes
Circulation,
September 7, 2004;
110(10):
1269 - 1275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, S. Di Biase, T. Russo, D. Labella, F. Zullo, G. Lombardi, and A. Colao
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4588 - 4593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Morin-Papunen, K. Rautio, A. Ruokonen, P. Hedberg, M. Puukka, and J. S. Tapanainen
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
4649 - 4654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Treiber, P. Barbeau, G. Harshfield, H.-S. Kang, D. M. Pollock, J. S. Pollock, and H. Snieder
Endothelin-1 Gene LYS198ASN Polymorphism and Blood Pressure Reactivity
Hypertension,
October 1, 2003;
42(4):
494 - 499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Jin, J. Nakura, Z. Wu, M. Yamamoto, M. Abe, Y. Tabara, Y. Yamamoto, M. Igase, K. Kohara, and T. Miki
Association of Endothelin-1 Gene Variant With Hypertension
Hypertension,
January 1, 2003;
41(1):
163 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Mather, B. Mirzamohammadi, A. Lteif, H. O. Steinberg, and A. D. Baron
Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes
Diabetes,
December 1, 2002;
51(12):
3517 - 3523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Quehenberger, M. Exner, R. Sunder-Plassmann, K. Ruzicka, C. Bieglmayer, G. Endler, C. Muellner, W. Speiser, and O. Wagner
Leptin Induces Endothelin-1 in Endothelial Cells In Vitro
Circ. Res.,
April 5, 2002;
90(6):
711 - 718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Asai, T. Ohkubo, T. Katsuya, J. Higaki, Y. Fu, M. Fukuda, A. Hozawa, M. Matsubara, H. Kitaoka, I. Tsuji, et al.
Endothelin-1 Gene Variant Associates With Blood Pressure in Obese Japanese Subjects: The Ohasama Study
Hypertension,
December 1, 2001;
38(6):
1321 - 1324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Diamanti-Kandarakis, G. Spina, C. Kouli, and I. Migdalis
Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy
J. Clin. Endocrinol. Metab.,
October 1, 2001;
86(10):
4666 - 4673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.J. Irving, J.P. Noon, G.C.M. Watt, D.J. Webb, and B.R. Walker
Activation of the endothelin system in insulin resistance
QJM,
June 1, 2001;
94(6):
321 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Ishibashi, T. Imamura, P. M. Sharma, S. Ugi, and J. M. Olefsky
The Acute and Chronic Stimulatory Effects of Endothelin-1 on Glucose Transport Are Mediated by Distinct Pathways in 3T3-L1 Adipocytes
Endocrinology,
December 1, 2000;
141(12):
4623 - 4628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ferri, G. Desideri, M. Valenti, C. Bellini, M. Pasin, A. Santucci, and Giancarlo De Mattia
Early Upregulation of Endothelial Adhesion Molecules in Obese Hypertensive Men
Hypertension,
October 1, 1999;
34(4):
568 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tiret, O. Poirier, V. Hallet, T. A. McDonagh, C. Morrison, J. J. V. McMurray, H. J. Dargie, D. Arveiler, J.-B. Ruidavets, G. Luc, et al.
The Lys198Asn Polymorphism in the Endothelin-1 Gene Is Associated With Blood Pressure in Overweight People
Hypertension,
May 1, 1999;
33(5):
1169 - 1174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ferri, C. Bellini, G. Desideri, E. Giuliani, L. De Siati, S. Cicogna, and A. Santucci
Clustering of Endothelial Markers of Vascular Damage in Human Salt-Sensitive Hypertension : Influence of Dietary Sodium Load and Depletion
Hypertension,
November 1, 1998;
32(5):
862 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Thorin, P. Cernacek, and J. Dupuis
Endothelin-1 Regulates Tone of Isolated Small Arteries in the Rat : Effect of Hyperendothelinemia
Hypertension,
April 1, 1998;
31(4):
1035 - 1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Scherrer and C. Sartori
Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity
Circulation,
December 2, 1997;
96(11):
4104 - 4113.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Z. K. Krowicki, N. A. Nathan, and P. J. Hornby
Excitatory Gastric Motor and Cardiovascular Effects of Endothelins in the Dorsal Vagal Complex are Mediated Through ETA Receptors
J. Pharmacol. Exp. Ther.,
August 1, 1997;
282(2):
535 - 542.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Quehenberger, M. Exner, R. Sunder-Plassmann, K. Ruzicka, C. Bieglmayer, G. Endler, C. Muellner, W. Speiser, and O. Wagner
Leptin Induces Endothelin-1 in Endothelial Cells In Vitro
Circ. Res.,
April 5, 2002;
90(6):
711 - 718.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|